サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1756603

肺塞栓症治療薬の世界市場 2025年～2029年

Global Pulmonary Embolism Therapeutics Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 206 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
肺塞栓症治療薬の世界市場 2025年～2029年
出版日: 2025年06月12日
発行: TechNavio
ページ情報: 英文 206 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肺塞栓症治療薬市場は2024年～2029年に166億9,340万米ドル、予測期間中のCAGRは11.7%で成長すると予測されます。

当レポートでは、肺塞栓症治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。有害な健康状態のリスクの高まり、老人人口の増加、肺塞栓症治療薬の研究開発活動の活発化などが市場を牽引しています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 10.2%
CAGR 11.7%
増分額 166億9,340万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の肺塞栓症治療薬市場の成長を促進する主な要因の一つとして、ヘルスケアおよび医療分野の進歩を挙げています。また、肺塞栓症に関する意識の高まりや、治療薬に関する提携や共同研究の増加が、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024年～2029年

第5章 市場規模実績

  • 肺塞栓症治療薬の世界市場 2019年～2023年
  • 用途別セグメント分析 2019年～2023年
  • 投与経路別セグメント分析 2019年～2023年
  • 薬物クラス別セグメント分析 2019年～2023年
  • 地域別セグメント分析 2019年～2023年
  • 国別セグメント分析 2019年～2023年

第6章 定性分析

  • AIの影響：肺塞栓症治療薬の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：用途別

  • 市場セグメント
  • 比較：用途別
  • 病院：市場規模と予測 2024年～2029年
  • 外来手術センター：市場規模と予測 2024年～2029年
  • 調査機関：市場規模と予測 2024年～2029年
  • 市場機会：用途別

第9章 市場セグメンテーション：投与経路別

  • 市場セグメント
  • 比較：投与経路別
  • 経口：市場規模と予測 2024年～2029年
  • 非経口：市場規模と予測 2024年～2029年
  • 市場機会：投与経路別

第10章 市場セグメンテーション：薬剤クラス別

  • 市場セグメント
  • 比較：薬剤クラス別
  • 直接経口抗凝固薬（DOAC）：市場規模と予測 2024年～2029年
  • ヘパリンビタミンK：市場規模と予測 2024年～2029年
  • 拮抗薬：市場規模と予測 2024年～2029年
  • 市場機会：薬剤クラス別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024年～2029年
  • 欧州：市場規模と予測 2024年～2029年
  • アジア：市場規模と予測 2024年～2029年
  • 世界のその他の地域：市場規模と予測 2024年～2029年
  • 米国：市場規模と予測 2024年～2029年
  • カナダ：市場規模と予測 2024年～2029年
  • フランス：市場規模と予測 2024年～2029年
  • 日本：市場規模と予測 2024年～2029年
  • ノルウェー：市場規模と予測 2024年～2029年
  • ブラジル：市場規模と予測 2024年～2029年
  • 英国：市場規模と予測 2024年～2029年
  • 中国：市場規模と予測 2024年～2029年
  • ドイツ：市場規模と予測 2024年～2029年
  • イタリア：市場規模と予測 2024年～2029年
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann La Roche Ltd.
  • Inari Medical Inc.
  • Johnson and Johnson Services Inc.
  • Medtronic Plc
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Viatris Inc.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Application - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Application - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Application
  • Exhibits41: Data Table on Comparison by Application
  • Exhibits42: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Research institutes - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Market opportunity by Application ($ million)
  • Exhibits55: Data Table on Market opportunity by Application ($ million)
  • Exhibits56: Chart on Route of Administration - Market share 2024-2029 (%)
  • Exhibits57: Data Table on Route of Administration - Market share 2024-2029 (%)
  • Exhibits58: Chart on Comparison by Route of Administration
  • Exhibits59: Data Table on Comparison by Route of Administration
  • Exhibits60: Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Parenteral - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Market opportunity by Route of Administration ($ million)
  • Exhibits69: Data Table on Market opportunity by Route of Administration ($ million)
  • Exhibits70: Chart on Drug Class - Market share 2024-2029 (%)
  • Exhibits71: Data Table on Drug Class - Market share 2024-2029 (%)
  • Exhibits72: Chart on Comparison by Drug Class
  • Exhibits73: Data Table on Comparison by Drug Class
  • Exhibits74: Chart on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
  • Exhibits75: Data Table on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
  • Exhibits76: Chart on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
  • Exhibits77: Data Table on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
  • Exhibits78: Chart on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Antagonists - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Antagonists - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Antagonists - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Antagonists - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Market opportunity by Drug Class ($ million)
  • Exhibits87: Data Table on Market opportunity by Drug Class ($ million)
  • Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits91: Chart on Geographic comparison
  • Exhibits92: Data Table on Geographic comparison
  • Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Norway - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Norway - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Norway - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Norway - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Market opportunity By Geographical Landscape ($ million)
  • Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits151: Impact of drivers and challenges in 2024 and 2029
  • Exhibits152: Overview on criticality of inputs and factors of differentiation
  • Exhibits153: Overview on factors of disruption
  • Exhibits154: Impact of key risks on business
  • Exhibits155: Companies covered
  • Exhibits156: Company ranking index
  • Exhibits157: Matrix on companies position and classification
  • Exhibits158: AbbVie Inc. - Overview
  • Exhibits159: AbbVie Inc. - Product / Service
  • Exhibits160: AbbVie Inc. - Key news
  • Exhibits161: AbbVie Inc. - Key offerings
  • Exhibits162: SWOT
  • Exhibits163: Astellas Pharma Inc. - Overview
  • Exhibits164: Astellas Pharma Inc. - Product / Service
  • Exhibits165: Astellas Pharma Inc. - Key offerings
  • Exhibits166: SWOT
  • Exhibits167: Bayer AG - Overview
  • Exhibits168: Bayer AG - Business segments
  • Exhibits169: Bayer AG - Key news
  • Exhibits170: Bayer AG - Key offerings
  • Exhibits171: Bayer AG - Segment focus
  • Exhibits172: SWOT
  • Exhibits173: Boehringer Ingelheim International GmbH - Overview
  • Exhibits174: Boehringer Ingelheim International GmbH - Product / Service
  • Exhibits175: Boehringer Ingelheim International GmbH - Key news
  • Exhibits176: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits177: SWOT
  • Exhibits178: Bristol Myers Squibb Co. - Overview
  • Exhibits179: Bristol Myers Squibb Co. - Product / Service
  • Exhibits180: Bristol Myers Squibb Co. - Key news
  • Exhibits181: Bristol Myers Squibb Co. - Key offerings
  • Exhibits182: SWOT
  • Exhibits183: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibits184: Daiichi Sankyo Co. Ltd. - Product / Service
  • Exhibits185: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibits186: SWOT
  • Exhibits187: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits188: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits189: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits190: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits191: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits192: SWOT
  • Exhibits193: Inari Medical Inc. - Overview
  • Exhibits194: Inari Medical Inc. - Product / Service
  • Exhibits195: Inari Medical Inc. - Key offerings
  • Exhibits196: SWOT
  • Exhibits197: Johnson and Johnson Services Inc. - Overview
  • Exhibits198: Johnson and Johnson Services Inc. - Business segments
  • Exhibits199: Johnson and Johnson Services Inc. - Key news
  • Exhibits200: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits201: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits202: SWOT
  • Exhibits203: Medtronic Plc - Overview
  • Exhibits204: Medtronic Plc - Business segments
  • Exhibits205: Medtronic Plc - Key news
  • Exhibits206: Medtronic Plc - Key offerings
  • Exhibits207: Medtronic Plc - Segment focus
  • Exhibits208: SWOT
  • Exhibits209: Novartis AG - Overview
  • Exhibits210: Novartis AG - Business segments
  • Exhibits211: Novartis AG - Key news
  • Exhibits212: Novartis AG - Key offerings
  • Exhibits213: Novartis AG - Segment focus
  • Exhibits214: SWOT
  • Exhibits215: Pfizer Inc. - Overview
  • Exhibits216: Pfizer Inc. - Product / Service
  • Exhibits217: Pfizer Inc. - Key news
  • Exhibits218: Pfizer Inc. - Key offerings
  • Exhibits219: SWOT
  • Exhibits220: Sanofi SA - Overview
  • Exhibits221: Sanofi SA - Business segments
  • Exhibits222: Sanofi SA - Key news
  • Exhibits223: Sanofi SA - Key offerings
  • Exhibits224: Sanofi SA - Segment focus
  • Exhibits225: SWOT
  • Exhibits226: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits227: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits228: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits229: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits230: SWOT
  • Exhibits231: Viatris Inc. - Overview
  • Exhibits232: Viatris Inc. - Business segments
  • Exhibits233: Viatris Inc. - Key news
  • Exhibits234: Viatris Inc. - Key offerings
  • Exhibits235: Viatris Inc. - Segment focus
  • Exhibits236: SWOT
  • Exhibits237: Inclusions checklist
  • Exhibits238: Exclusions checklist
  • Exhibits239: Currency conversion rates for US$
  • Exhibits240: Research methodology
  • Exhibits241: Information sources
  • Exhibits242: Data validation
  • Exhibits243: Validation techniques employed for market sizing
  • Exhibits244: Data synthesis
  • Exhibits245: 360 degree market analysis
  • Exhibits246: List of abbreviations
目次
Product Code: IRTNTR75721

The pulmonary embolism therapeutics market is forecasted to grow by USD 16,693.4 mn during 2024-2029, accelerating at a CAGR of 11.7% during the forecast period. The report on the pulmonary embolism therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing risk of adverse health conditions, increase in geriatric population, and rise in research and development activities for pulmonary embolism therapeutics.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 202510.2%
CAGR11.7%
Incremental Value$16,693.4 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's pulmonary embolism therapeutics market is segmented as below:

By Application

    • Hospitals
    • Ambulatory surgical centers
    • Research institutes

By Route Of Administration

    • Oral
    • Parenteral

By Drug Class

    • Direct oral anticoagulants (DOACs)
    • Heparins vitamin K
    • Antagonists

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the advancements in healthcare and medical sector as one of the prime reasons driving the pulmonary embolism therapeutics market growth during the next few years. Also, increasing awareness regarding pulmonary embolism and growing number of partnerships and collaborations on therapeutics will lead to sizable demand in the market.

The report on the pulmonary embolism therapeutics market covers the following areas:

    • Pulmonary Embolism Therapeutics Market sizing
    • Pulmonary Embolism Therapeutics Market forecast
    • Pulmonary Embolism Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pulmonary embolism therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Inari Medical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Novartis AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the pulmonary embolism therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by Drug Class
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Pulmonary Embolism Therapeutics Market 2019 - 2023
    • Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2019 - 2023 ($ million)
  • 5.2 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.3 Route of Administration segment analysis 2019 - 2023
    • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • 5.4 Drug Class segment analysis 2019 - 2023
    • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on global pulmonary embolism therapeutics market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

  • 8.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 8.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 8.3 Hospitals - Market size and forecast 2024-2029
    • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • 8.4 Ambulatory surgical centers - Market size and forecast 2024-2029
    • Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
    • Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
    • Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
    • Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
  • 8.5 Research institutes - Market size and forecast 2024-2029
    • Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
    • Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
    • Chart on Research institutes - Year-over-year growth 2024-2029 (%)
    • Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Route of Administration

  • 9.1 Market segments
    • Chart on Route of Administration - Market share 2024-2029 (%)
    • Data Table on Route of Administration - Market share 2024-2029 (%)
  • 9.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 9.3 Oral - Market size and forecast 2024-2029
    • Chart on Oral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • 9.4 Parenteral - Market size and forecast 2024-2029
    • Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
    • Chart on Parenteral - Year-over-year growth 2024-2029 (%)
    • Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
  • 9.5 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by Drug Class

  • 10.1 Market segments
    • Chart on Drug Class - Market share 2024-2029 (%)
    • Data Table on Drug Class - Market share 2024-2029 (%)
  • 10.2 Comparison by Drug Class
    • Chart on Comparison by Drug Class
    • Data Table on Comparison by Drug Class
  • 10.3 Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029
    • Chart on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
    • Chart on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
    • Data Table on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
  • 10.4 Heparins vitamin K - Market size and forecast 2024-2029
    • Chart on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
    • Data Table on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
    • Chart on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
    • Data Table on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
  • 10.5 Antagonists - Market size and forecast 2024-2029
    • Chart on Antagonists - Market size and forecast 2024-2029 ($ million)
    • Data Table on Antagonists - Market size and forecast 2024-2029 ($ million)
    • Chart on Antagonists - Year-over-year growth 2024-2029 (%)
    • Data Table on Antagonists - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by Drug Class
    • Market opportunity by Drug Class ($ million)
    • Data Table on Market opportunity by Drug Class ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.9 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.10 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.11 Norway - Market size and forecast 2024-2029
    • Chart on Norway - Market size and forecast 2024-2029 ($ million)
    • Data Table on Norway - Market size and forecast 2024-2029 ($ million)
    • Chart on Norway - Year-over-year growth 2024-2029 (%)
    • Data Table on Norway - Year-over-year growth 2024-2029 (%)
  • 12.12 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.13 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.14 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.15 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.16 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 15.5 Astellas Pharma Inc.
    • Astellas Pharma Inc. - Overview
    • Astellas Pharma Inc. - Product / Service
    • Astellas Pharma Inc. - Key offerings
    • SWOT
  • 15.6 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 15.7 Boehringer Ingelheim International GmbH
    • Boehringer Ingelheim International GmbH - Overview
    • Boehringer Ingelheim International GmbH - Product / Service
    • Boehringer Ingelheim International GmbH - Key news
    • Boehringer Ingelheim International GmbH - Key offerings
    • SWOT
  • 15.8 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
    • SWOT
  • 15.9 Daiichi Sankyo Co. Ltd.
    • Daiichi Sankyo Co. Ltd. - Overview
    • Daiichi Sankyo Co. Ltd. - Product / Service
    • Daiichi Sankyo Co. Ltd. - Key offerings
    • SWOT
  • 15.10 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.11 Inari Medical Inc.
    • Inari Medical Inc. - Overview
    • Inari Medical Inc. - Product / Service
    • Inari Medical Inc. - Key offerings
    • SWOT
  • 15.12 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
    • SWOT
  • 15.13 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT
  • 15.14 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 15.15 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.16 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 15.17 Takeda Pharmaceutical Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd. - Overview
    • Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Takeda Pharmaceutical Co. Ltd. - Key news
    • Takeda Pharmaceutical Co. Ltd. - Key offerings
    • SWOT
  • 15.18 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations